asuhowe: I'm with you on this one. I'd take $2.00 a share in a heartbeat as opposed to watching the stock drop half its value again after another toxic refinancing and then having to wait 2 or 3 more years for any progress. The company's problems haven't been all the fault of management. I'd put 80% of the blame on the FDA and the artifact fiasco. But some stocks are just snakebit. So, yeah, I'd jump at $2.00 a share and I'd buy more GDX or TBT. Both are sure doubles this year.
News 
Market Data 
Discover 
AI
